Vascarta Inc. — Form D/A
Vascarta Inc. of SUMMIT, NJ, a company, filed a Form D amendment with the SEC on 2022-03-11. $75K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-03-11
- Form: D/A
- Accession: 0001823616-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $75K
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2022-02-24
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-436856
Issuer
- Name: Vascarta Inc.
- CIK: 0001823616
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4 CHATHAM ROAD, SUMMIT, NJ, 07901
- Phone: 9733217521
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Joel Friedman, MD, PhD | Director | Summit, NJ |
| Travis Gering | Director | Summit, NJ |
| Richard Prince, PhD | Director | Summit, NJ |
| Joel Friedman, MD, PhD | Executive Officer | Summit, NJ |
| Travis Gering | Executive Officer | Summit, NJ |
| Richard Prince, PhD | Executive Officer | Summit, NJ |
| Graeme Silbert | Executive Officer | Summit, NJ |
Other filings by this issuer (3)
More